$STAB News February 15, 2022 Statera Biopharma, I
Post# of 24768
![](/assets/46931549/no_avatar_available_thumb.jpg)
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)